Quantitative proteomic analysis of HER2 expression in the selection of gastric cancer patients for trastuzumab treatment.
Quantitative proteomic analysis of HER2 expression in the selection of gastric cancer patients for trastuzumab treatment. Ann Oncol. 2017 01 01; 28(1):110-115.